Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon

Jacques Banchereau, Hideki Ueno, Madhav Dhodapkar, John Connolly, Jennifer P. Finholt, Eynav Klechevsky, Jean Philippe Blanch, Dennis A. Johnston, A. Karolina Palucka, Joseph Fay

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon'. Together they form a unique fingerprint.

Medicine & Life Sciences